Jastreboff AM et al., Phase 2 retatrutide, NEJM 2023 (NEJMoa2301972, PMID 37366315) -24,2% at 48 weeks at the 12 mg level
To date, the GLP-1 Supply Tracker has generated more than 50,000 crowdsourced shortage reports and thousands of supply reports, data which Ro has shared with the FDA
Accessed 20 Nov 2021 Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
For researchers serious about navigating their GLP-1 options with confidence, SeekPeptides provides the most comprehensive educational resource available, with evidence-based guides on every major GLP-1 medication, dosage calculators , comparison tools, and a community of knowledgeable members who have navigated these exact conversations successfully